Research & Innovation
Novel therapy using engineered immune cells to kill prostate cancer earns $1.8 million Department of Defense grant
Jan 20, 2026Massey and VCU Institute of Molecular Medicine (VIMM) researchers were awarded a $1.8 million grant from the United States Department of Defense (DoD) to study the implications of using modified enhanced therapeutic versions of melanoma differentiation associated gene-7/Interleukin-24, IL-24. ...